Company profile for Morphic Therapeutic

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Morphic Therapeutic is leading the development of a new generation of oral integrin drugs, informed by decades of world-leading expertise and a unique integrin discovery platform. Morphic believes oral drugs targeting the integrin protein family can transform the treatment paradigm for patients suffering from serious chronic diseases, including autoimmune, cardiovascular and metabolic diseases, as well as fibrosis and cancer. ...
Morphic Therapeutic is leading the development of a new generation of oral integrin drugs, informed by decades of world-leading expertise and a unique integrin discovery platform. Morphic believes oral drugs targeting the integrin protein family can transform the treatment paradigm for patients suffering from serious chronic diseases, including autoimmune, cardiovascular and metabolic diseases, as well as fibrosis and cancer. Morphic has established strategic partnerships which have dramatically expanded the scope of its discovery activity, potential pipeline breadth, and growth of its internal capabilities.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
35 Gatehouse Drive, A2 Waltham, MA 02451
Telephone
Telephone
+1- (781) 996-0955
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more
Lilly Completes $3.2B Acquisition of Morphic
Lilly Completes $3.2B Acquisition of Morphic

19 Aug 2024

// CONTRACT PHARMA

https://www.contractpharma.com/contents/view_breaking-news/2024-08-16/lilly-completes-32b-acquisition-of-morphic/?widget=listSection

CONTRACT PHARMA
19 Aug 2024

https://www.prnewswire.com/news-releases/lilly-completes-acquisition-of-morphic-to-improve-outcomes-and-expand-options-for-people-living-with-inflammatory-bowel-disease-302224347.html

PR NEWSWIRE
16 Aug 2024

https://investor.lilly.com/news-releases/news-release-details/lilly-acquire-morphic-improve-outcomes-patients-inflammatory

PRESS RELEASE
08 Jul 2024

https://www.globenewswire.com/news-release/2024/05/31/2891485/0/en/Morphic-to-Participate-in-Jefferies-Global-Healthcare-Conference.html

GLOBENEWSWIRE
31 May 2024

https://www.globenewswire.com/news-release/2024/05/21/2885527/0/en/Morphic-Demonstrates-Novel-Real-Time-Visualization-of-Small-Molecule-%CE%B14%CE%B27-Inhibition-of-Gut-Trafficking-Cells.html

GLOBENEWSWIRE
21 May 2024

https://www.globenewswire.com/news-release/2024/05/09/2879176/0/en/Morphic-to-Participate-in-RBC-Capital-Markets-Global-Healthcare-Conference.html

GLOBENEWSWIRE
09 May 2024

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty